Buy Zydus Lifesciences, target price Rs 530: Yes SecuritiesBullish ABC breakout suggests follow through moves on P&F chart.
17 Mar, 2023, 09.09 AM IST
Buy Zydus Lifesciences, target price Rs 572: Sharekhan by BNP ParibasZydus Lifesciences, incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 46161.57 Crore) operating in Pharmaceu...
27 Feb, 2023, 12.49 PM IST
Buy Zydus Lifesciences, target price Rs 485: JM FinancialZydus Lifesciences, incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 47583.72 Crore) operating in Pharmaceu...
06 Feb, 2023, 12.56 PM IST
Buy Zydus Lifesciences, target price Rs 488: HDFC SecuritiesStock price is in an attempt of decisive upside break-out of resistance of top of Nov at Rs 454 levels.
11 Jan, 2023, 09.37 AM IST
Buy Zydus Lifesciences, target price Rs 470: JM FinancialZydus Lifesciences Ltd., incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 42548.00 Crore) operating in Phar...
27 Dec, 2022, 01.23 PM IST
Buy Zydus Lifesciences., target price Rs 426: Angel OnePromoters held 74.98 per cent stake in the company as of 30-Sep-2022, while FIIs owned 2.86 per cent, DIIs 12.85 per cent.
21 Dec, 2022, 10.37 AM IST
Genetek Lifesciences to manufacture Amphotericin B injection for black fungus treatmentGenetek Lifesciences started production of Remdesivir injections, used in the treatment of COVID-19, in Wardha from Wednesday.
14 May, 2021, 11.43 PM IST
Remdesivir production expected to start in Wardha from WednesdayRemdesivir is approved in India for restricted emergency use for the treatment of suspected or laboratory confirmed COVID-19 in adults and ...
27 Apr, 2021, 04.55 PM IST
Govt may provide tax incentives for startups in BudgetStartup India initiative of the government aims at fostering entrepreneurship and promoting innovation by creating an ecosystem that is con...
30 Dec, 2019, 03.57 PM IST
Top gainers and losers of Monday's sessionIn the Nifty50 pack, 35 stocks settled in green, while 16 in red.
28 Aug, 2017, 04.11 PM IST
Market Now: Nearly 40 stocks hit fresh 52-week highs todayIn the Nifty50 pack, 40 stocks were trading in green, while 11 stocks were in red.
28 Aug, 2017, 10.35 AM IST
Top gainers and losers of Wednesday's sessionIn the Nifty50 pack, 36 stocks settled in green, while 15 in red.
23 Aug, 2017, 03.56 PM IST
Market Now: Over 60 stocks hit fresh 52-week highsIn the Nifty50 pack, 33 stocks were trading in green, while 18 stocks were in red.
23 Aug, 2017, 10.38 AM IST
FIPB clears 5 FDI proposals worth Rs 6,050 crore, Cadila gets nodCadila will infuse equity of up to Rs 5,000 crore through issue of shares to QIBs through Qualified Institutional Placement for expansion.
14 Jan, 2016, 01.31 PM IST
Swedish firm Recipharm buys majority stake in Nitin Lifesciences for Rs 671 croreSwedish contract drug manufacturing firm Recipharm has acquired a 74% stake in Nitin Lifesciences, a privately held sterile injectables man...
21 Oct, 2015, 03.11 AM IST
Recipharm to take majority stake in Nitin Life for Rs 671 croreThe Sweden-based drug firm Recipharm has entered into an agreement to acquire a majority stake in Nitin Lifesciences Ltd.
20 Oct, 2015, 02.59 PM IST
- Stocks to watch: Wipro, Lupin, NTPC, Himatsingka Seide, Videocon, Ranbaxy
Wipro’s consolidated net sales for quarter ended December stood at Rs 6963.40 crore against Rs 6940.20 crore. Net profit rose to Rs 1217.40...
20 Jan, 2010, 08.56 AM IST